On Saturday, 9/6 at the #SH25 Workshop in Cincinnati, learn about EBV+ lymphoproliferative disorders from Ashish Kumar, MD, PhD from Cincinnati Children’s Hospital. Register here! https://t.co/z9ZEgS4F2B #SH25#hemepath#lymsm
Join us at the 2025 SH-EA4HP Workshop, Sept. 4-6 in Cincinatti. On 9/5, Dr. Jeffrey Klco MD, PhD, will speak about “Advances in the Molecular Characterization of Pediatric AML.” For more information: https://t.co/WUmvdrP4hP #SH25#leusm#hemepath
At the #SH25 Workshop, learn about transient abnormal myelopoiesis and myeloid leukemia of Down Syndrome from renowned expert, Johann (Hans) Hitzler, MD. Join us in Cincinnati Sept. 4-6! Register at https://t.co/z9ZEgS4F2B #hemepath#leusm
Join us at the 2025 SH-EA4HP Workshop. On Thursday Sept 4th, Dr. Mike Borowitz, MD, PhD, from Johns Hopkins University, will speak about 'New Entities in ALL & Updates in MRD.' Make sure to register. More information: https://t.co/z9ZEgS4F2B
#SH25#leusm#lymsm#hemepath#pathx
Join us at the 2025 SH-EA4HP Workshop. Sept 4-6, in Cincinnati, OH. You will see fascinating cases with renowned speakers presenting the latest in pediatric and young adult #Hemepath. Make sure to register! More information in SH-EAHP 2025 Workshop#SH25 #leusm#lymsm
🎉Congratulations to all the newly-matched future #HemePath fellows! To view your result, log in to the NRMP website: https://t.co/v47MLxAPrO.
Share where you matched with #HemePathMatch26#FellowMatch !
For more information check out SH’s webpage: https://t.co/5eAeXdy423
Are you a pathology trainee interested in a #hemepath fellowship? Big news: most hemepath fellowship programs will be moving to a match process for positions that begin in 2026! For more information: https://t.co/2WFaouRS8t
The WHO Classification of Haematolymphoid Tumours, 5th edition, is now finalized 👏😊 and is available on-line at
https://t.co/c1bweKYbJV
It will soon be available as a two volume printed book. #hemepath#lymphoma#WHO
Pure erythroid leukemia
->80% marrow erythroid cells (>30% pronormoblasts); no increase myeloblasts
-Rare (~1% AML), aggressive course
-Pronormoblasts - large, pale blue cytoplasm, open evenly distributed chromatin and prominent nucleoli
-Complex karyotypes ~almost all cases
ABPath announced today that all future Primary and Subspecialty exams will be administered exclusively at commercial testing centers. Read the full announcement at https://t.co/vAfbtC1ERY #pathology#pathboards
A tribute to #eosinophils from a comparative and evolutionary perspective (source: Journal of Allergy and Clinical Immunology Volume 147 Issue 3 Pages 1115-1116 (March 2021) DOI: 10.1016/j.jaci.2020.12.002). Wright-Giemsa stain. ×100 objective.
Check out these fantastic and short lectures (" Molecular in a Minute") on various molecular #pathology topics. " ALL FREE", and one time enrollment is good for all lectures. @AMPath@AlannaChurch_MD@akkari_yassmine @NateBaileyMD @sabahkadri
https://t.co/WfYAxxXtbR
R/R extra-nodal NK/T-cell lymphoma high response with pembrolizumab (anti-PD1 antibody). Paper NCCN cites uses the SP263 clone (we have 22C3 & SP142), both look positive.. Some evidence IHC may not be best method to detect response (structural rearrangements PDL1 may be better?)